Digitally-Augmented Therapies

Voluntis enhances treatment experiences by empowering patients and
their care team with personalized, algorithms-based digital therapeutics.

What’s new

Finance 18 October 2021

Voluntis announces the success of the Tender Offer initiated by the Aptar company allowing the implementation of mandatory squeeze-out

Learn more
Product 7 June 2021

Voluntis receives FDA 510(k) clearance for a new version of Insulia supporting an expanded range of basal insulins

Learn more
A trusted partner of leading pharmaceutical companies at a global level.
WHO WE ARE

Meet our expert teams

We are a passionate and cross-functional team made up of experts. Each of us has a unique experience in supporting pharma digital therapeutics (DTx) initiatives from inception to real-world operation. From clinical design and system architecture to regulatory affairs, from human factors engineering to global technical operations, we support our pharmaceutical partners at every stage of the digital therapeutics life cycle, implementing the industry’s best practices. Every day, we work hard to deliver together the best solutions for patients and their care team.

Join Voluntis
Scientist working on improving treatment
OUR SCIENTIFIC APPROACH

An organization
driven by science

Embedding evidence-based clinical algorithms, our digital therapeutics deliver automated and personalized recommendations to patients to enhance their treatment experience and support the collaboration with their care team. Our algorithms are developed by our in-house team of doctors, pharmacists and engineers, working hand-in-hand with patients, healthcare professionals and the scientific teams of our pharmaceutical partners to build digitally-augmented therapies adapted to the users’ needs.

OUR CORE-PLATFORM

Theraxium, the leading platform for digitally-augmented therapies

Theraxium is the cornerstone of all the digital solutions we develop together with our life sciences partners. It provides a highly flexible architecture supported by a library of reusable off-the-shelf components and algorithms dedicated to pharma digital therapeutics. It is also a robust infrastructure guaranteeing compliance with applicable medical device and data privacy regulations. Theraxium has been used to support 14 successful regulatory clearances for pharma-partnered digital therapeutics in the US, Europe and Canada.

14 regulatory clearances
  • ISO 13485

  • gdpr

  • hipaa

  • mdsap USA & Canada

Learn More
 Process of diitally augmented therapies